** Shares of Scynexis Inc SCYX.O rise 3.7% to $3.06
premarket
** Co says its Q4 loss was 30 cents per share, compared with
a loss of $1.05 per share reported last year, and beat Refinitiv
estimate of 44 cents loss per share
** Says its revenue in Q4 jumped to $1.4 mln from $600,00
last year, and was in line with analysts' estimates
** Shares of co hit their highest level since October on
Thursday after it signed an exclusive licence agreement for
fungal infection treatment with GSK Plc GSK.L
** Stock doubled this year, as of last close
(Reporting by Tejaswi Marthi in Bengaluru)
((tejaswi.marthi@thomsonreuters.com))